ERK-mTOR crosstalk suppresses autophagy and upregulates proteasomal degradation pathway to confer chronic myeloid leukemia cells resistant to imatinib.
Saved in:
| Title: | ERK-mTOR crosstalk suppresses autophagy and upregulates proteasomal degradation pathway to confer chronic myeloid leukemia cells resistant to imatinib. |
|---|---|
| Authors: | Roy R; Department of Life Sciences, Presidency University, Kolkata, India., Paul T; Department of Life Sciences, Presidency University, Kolkata, India., Das PK; Department of Life Sciences, Presidency University, Kolkata, India., Sinha S; Department of Life Sciences, Presidency University, Kolkata, India., Ray SS; Institute of Hematology & Transfusion Medicine, Medical College Kolkata, India., Bhattacharyya M; Institute of Hematology & Transfusion Medicine, Medical College Kolkata, India., Biswas N; Department of Life Sciences, Presidency University, Kolkata, India. Electronic address: nabendu.dbs@presiuniv.ac.in. |
| Source: | Experimental hematology [Exp Hematol] 2026 Feb; Vol. 154, pp. 105330. Date of Electronic Publication: 2025 Nov 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-2399 |
|---|---|
| DOI: | 10.1016/j.exphem.2025.105330 |
